Argentina Pulmonary Arterial Hypertension Market Outlook

the outlook of the argentina pulmonary arterial hypertension market has been positive, with a number of new therapeutic treatments being developed in recent years. the number of patients suffering from pulmonary arterial hypertension (pah) is increasing in argentina due to an increase in lifestyle-related diseases, such as diabetes and hypertension. the trend, coupled with aging populations, is expected to lead to an increase in the number of pah patients among the population of argentina. in 2020, pah was listed as a rare disease in argentina and became eligible for government subsidies. the introduction of the new subsidies has led to a rapid expansion of the number of pah treatments available in the country. this has been further aided by the introduction of a national registry of pah treatments, which allows the government and caregivers to track pah treatment availability and access. in recent years, the argentine research and development community has seen pah as an area of focus for development of new therapies. pharmaceutical companies such as glaxosmithkline, almirall, and pfizer are in the process or have recently completed phase iii clinical trials for a number of new pah treatments. these drugs, if approved and brought to the market, could provide a major boost to the pah treatment landscape in argentina. furthermore, the telemedicine sector has seen a great deal of growth in argentina. in particular, telemedicine companies have successfully set up e-health platforms, such as telediagnosisas, to provide remote diagnosis and treatment to patients of pah. this has enabled a great deal of rural and remote patients to receive medical care without needing to travel. in terms of the outlook for the argentina pah market, investors and drugmakers are optimistic. with the recent expansion of government subsidies, the increasing availability of treatments, and the emergence of new technologies, there is no reason to believe that the trend of positive growth in the pah market will not continue in the future.